Form 4: Blueprint Medicines Director Sells Shares to Cover Tax Obligations

Director Jeffrey W. Albers sold 5,766 shares of Blueprint Medicines Corp to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 5, 2025, Jeffrey W. Albers, a director of Blueprint Medicines Corp, sold 5,766 shares of common stock.
• The sale was executed at a price of $88.8 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Albers directly owns 146,630 shares of Blueprint Medicines Corp.
• The sale was not a discretionary trade but an automatic 'sell to cover' transaction to satisfy tax obligations.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell to cover taxes) and doesn't indicate any significant positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and directors.

Stakeholder Impact

• The sale of shares could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates